Moreover, the loss of both BRG1 and BRM would favor the inhibition of DNA repair (2, 25), and in particular, such key DNA repair genes as GADD45 (26), which in turn could enhance tumor progression. The gene discussed is SMARCA4; the disease is neoplasm.